Skip to main content
SpringerLink
Log in

Investigation of the 5-hydroxytryptamine receptor mediating the “transient” short-circuit current response in guinea-pig ileal mucosa

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

5-Hydroxytryptamine (5-HT) stimulated an increase in short-circuit current (Isc) in guinea-pig isolated ileal mucosa over a wide concentration range (0.1 nM-0.1 mM). The concentration-response relationship was biphasic, consisting of a high potency phase (0.1 nM–1 μM) and a low potency phase (3–10 μM). Stimulation of Isc observed at the high potency phase tended to be sustained while responses at the low potency phase (3–10 μM) contained two components, an initial “transient” response followed by a “maintained” response. Both the high potency phase (maximum stimulation ∼30 μA cm−2) and the low potency phase (maximum stimulation ∼80 μA cm −2) 5-HT response were antagonized by tetrodotoxin (TTX, 0.3 μM) and atropine (1 μM). However, another low potency (3 μM-0.1 mM, maximum stimulation ∼30 μA cm−2) component of the 5-HT response was revealed in the presence of TTX or atropine.

In the presence of methysergide (1 μM), the concentration-response relationship of 5-HT was still biphasic and tropisetron (0.1 and 10 μM) antagonized both phases of the 5-HT response. In the presence of methysergide, the high potency phase 5-HT response was mimicked by 5-methoxytryptamine (5-MeOT) and the selective 5-HT4 agonist SC-53116 but not by BIMU 8. The potent 5-HT4 antagonist GR 113808 antagonized the response to 5-MeOT in a surmountable manner with an affinity estimate of 9.6 ± 0.3 (n = 4). The 5-MeOT stimulated increase in Isc was also antagonized in an unsurmountable manner by granisetron (1 μM).

In the presence of methysergide, desensitization of 5-HT3 receptors with 2-methyl-5-hydroxytryptamine (10 μM) abolished both phases of the 5-HT response. Under the same condition, desensitization of 5-HT4 receptors with 5-MeOT (10 μM) abolished only the high potency 5-HT response and dextrally shifted the low potency 5-HT response.

These data show that neuronal and non-neuronal 5-HT receptors are involved in the regulation of secretion in ileal mucosa. We propose the presence of a neuronal 5-HT4 receptor located upstream of the well characterized neuronal 5-HT3 receptors to be responsible for the high potency 5-HT response. A schematic model is proposed to explain our findings and the relationship between this 5-HT4 receptor and other 5-HT receptor subtypes regulating secretion that have been described in the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bockaert J, Fozard JR, Dumuis A, Clarke DE (1992) The 5-HT4 receptor: a place in the sun. Trends Pharmacol Sci 13:141–145

    Google Scholar 

  • Borman RA, Burleigh DE (1993) Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT. Br J Pharmacol 110:927–928

    Google Scholar 

  • Budhoo M, Grider J, Kellum J (1993) Serotonin (5-HT) induces rise in short circuit current (ISC) via 5-HT4 receptor in human jejunum in vitro. Exp Biol 93, New Orleans, Abstract No. 134

  • Bunce KT, Elswood CJ, Ball MT (1991) Investigation of the 5-hydroxytryptamine receptor mechanism mediating the short-circuit current response in rat colon. Br J Pharmacol 102: 811–816

    Google Scholar 

  • Burleigh DE, Borman RA (1993) Short-circuit current responses to 5-hydroxytryptamine in human ileal mucosa are mediated by a 5-HT4 receptor. Eur J Pharmacol 241:125–128

    Google Scholar 

  • Cooke JH, Carey HV (1985) Pharmacological analysis of 5-hydroxytryptamine actions on guinea pig ileal mucosa. Eur J Pharmacol 111:329–337

    Google Scholar 

  • Costa M, Furness JB, Cuello AC, Verhofstad AAJ, Steinbusch HWJ, Elde RP (1982) Neurones with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment. Neuroscience 7:351–363

    Google Scholar 

  • Craig DA, Eglen RM, Walsh LKM, Perkins LA, Whiting RL, Clarke DE (1990) 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine desensitization as discriminative tools for the 5-HT3 and putative 5-HT4 receptors in guinea-pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol: 342:9–16

    Google Scholar 

  • Dumuis A, Sebben M, Monferini E, Nicole M, Turconi M, Ladinsky H, Bockaert J (1991) Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain. NaunynSchmiedeberg's Arch Pharmacol 343:245–251

    Google Scholar 

  • Dumuis A, Gozlan H, Sebben M, Ansanay H, Rizzi CA, Turconi M, Monferini E, Giraldo E, Schiantarelli P, Ladinsky H, Bockaert J (1992) Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. NaunynSchmiedeberg's Arch Pharmacol 345:264–269

    Google Scholar 

  • Eglen RM, Swank SR, Walsh LKM, Whiting RL (1990) Characterization of 5-HT3 and ‘atypical’ 5-HT receptors mediating guineapig ileal contractions in vitro. Br J Pharmacol 101:513–520

    Google Scholar 

  • Eglen RM, Bley K, Bonhaus DW, Clark RD, Hegde SS, Johnson LG, Leung E, Whiting RL (1993) RS-23597–190: a potent and selective 5-HT4 receptor antagonist. Br J Pharmacol 110:119–126

    Google Scholar 

  • Erspamer V (1954) Pharmacology of indolealkyamines. Pharmacol Rev 6:425–487

    Google Scholar 

  • Flynn DL, Zabrowski DL, Becker DP, Nosal R, Villamil Cl, Gullikson GW, Moummi C, Yang D-C (1992) SC-53116: The first selective agonist at the newly identified serotonin 5-HT4 receptor subtype. J Med Chem 35:1486–1489

    Google Scholar 

  • Ford APDW, Clarke DE (1993) The 5-HT4 receptor. Med Res Rev 13:633–662

    Google Scholar 

  • Fox AJ, Morton IKM (1990) An examination of the 5-HT3 receptor mediating contraction and evoked [3H] -acetylcholine release in the guinea-pig ileum. Br J Pharmacol 101:553–556

    Google Scholar 

  • Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blashko H, Muscholl E (eds) Handbook of experimental pharmacology, catecholamines, vol 33. 1972; Springer, New York, pp 283–335

    Google Scholar 

  • Furness JB, Costa M (1982) Neurones with 5-hydroxytryptaminelike immunoreactivity in the enteric nervous system: their projections in the guinea-pig small intestine. Neuroscience 7:341–349

    Article  CAS  PubMed  Google Scholar 

  • Gale JD, Grossman CJ, Whitehead JWF, Oxford AW, Bunce KT, Humphrey PPA (1994) GR 113808: a novel selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol 111:332–338

    Google Scholar 

  • Gebauer A, Merger M, Kilbinger H (1993) Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine. Naunyn-Schmiedeberg's Arch Pharmacol 347:137–140

    Google Scholar 

  • Gershon MD, Tamir H (1981) Release of endogenous 5-hydroxytryptamine from resting and stimulated enteric neurones. Neuroscience 6:2277–2286

    Google Scholar 

  • Grossman CJ, Kilpatrick GJ, Bunce KT (1993) Development of a radioligand binding assay for 5-HT4 receptors in guinea pig and rat brain. Br J Pharmacol 109:618–624

    Google Scholar 

  • Hammer J, Philips SF, Talley NJ, Camilleri M (1993) Effect of a 5-HT3 antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther 7:543–551

    Google Scholar 

  • Hardcastle J, Hardcastle PT, Carstairs JWM, Franks CM (1994) Is desensitization of intestinal 5-hydroxytryptamine receptors an in-vitro phenomenon? J Pharm Pharmacol 46:322–325

    Google Scholar 

  • Hegde SS, Moy TM, Perry MR, Loeb M, Eglen RM (1994) Evidence for involvement of 5-HT4 receptors in 5-hydroxytryptophan-induced diarrhea in mice. J Pharmacol Exp Ther 271:741–747

    Google Scholar 

  • Hendriks R, Bornstein JC, Furness JB (1989) Evidence for two types of 5-hydroxytryptamine receptor on secretomotor neurones of the guinea pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 339:409–414

    Google Scholar 

  • Keast JR, Furness JB, Costa M (1985) Investigations of nerve populations influencing ion transport that can be stimulated electrically, by serotonin and by a nicotinic agonist. NaunynSchmiedeberg's Arch Pharmacol 331:260–266

    Google Scholar 

  • Leung E, Michelson S, Villarubia C, Perkins LA, Eglen RM (1992) Analysis concentration-response relationships by seemingly unrelated nonlinear regression (SUNR) technique. J Pharmacol Methods 28:209–216

    Google Scholar 

  • Leung E, Blissard D, Jett MF, Eglen RM (1993) Investigation of the 5-hydroxytryptamine receptor mediating the “transient” shortcircuit current response in guinea pig ileal mucosa. Experimental Biology 93, New Orleans, Abstract No 2785

  • McLean PG, Coupar IM, Molenaar P (1993) Effect of the novel 5-HT4 receptor agonist DAU 6236 in human colon. Medical J Aust 159:834

    Google Scholar 

  • Scott CM, Bunce KT, Spraggs CF (1992) Investigation of the 5-hydroxytryptamine receptor mediating the ‘maintained’ shortcircuit current response in guinea pig ileal mucosa. Br J Pharmacol 106:877–882

    Google Scholar 

  • Steadman CJ, Talley NJ, Philips SF, Zinsmeister AR (1992) Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome. A pilot study. Mayo Clin Proc 67:732–738

    Google Scholar 

  • Turconi M, Schiantarelli P, Borsini F, Rizzi CA, Ladinsky H, Donetti A (1991) Azabicycloalkyl benzimidazolones: Interaction with serotonergic 5-HT3 and 5-HT 4 receptors and potential therapeutic implications. Drugs Future 16:1011–1026

    Google Scholar 

  • Wardle KA, Ellis ES, Gaster LM, King FD, Sanger GJ (1993) SB 204070: A highly potent and selective 5-HT4 receptor antagonist. Br J Pharmacol 110, 15P

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, R2-101, Syntex Discovery Research, 3401 Hillview Avenue, 94304, Palo Alto, CA, USA

    E. Leung, D. Blissard, M. F. Jett & R. M. Eglen

Authors
  1. E. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Blissard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. F. Jett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. M. Eglen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leung, E., Blissard, D., Jett, M.F. et al. Investigation of the 5-hydroxytryptamine receptor mediating the “transient” short-circuit current response in guinea-pig ileal mucosa. Naunyn-Schmiedeberg's Arch Pharmacol 351, 596–602 (1995). https://doi.org/10.1007/BF00170158

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00170158

Key words

Search

Navigation